NL-OMON32482RecruitingPhase 2
Hepatocellular carcinoma: vascular abnormalities prior to, during and following systemic anti-cancer treatment - geen
Conditions
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Enrollment
- 28
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •advanced hepatocellular carcinoom.
- •Child-Pugh class B liver cirrhosis.
Exclusion Criteria
- •Major cardiac disease, HIV infection, serious active infectie
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Hepatocellular carcinoma: vascular abnormalities prior to, during and following systemic anti-cancer treatment - everolimus and capecitabine for HCCEUCTR2008-003972-23-NLMC
Completed
Not Applicable
Microvascular invasion of hepatocellular carcinoma predicts microvascular invasion of its recurrence.A potential implication for salvage liver transplantatioC22.0Liver cell carcinomaDRKS00024062Allgemein-, Viszeral- u. Transplantationschirurgie Universitätsmedizin Mainz37
Completed
Not Applicable
Mixed hepatocellular carcinoma and cholangiocarcinoma in liver transplantation: Prognostic factors for outcomes in Korea-Japan multicenter studyMixed hepatocellular carcinoma and cholangiocarcinomaJPRN-UMIN000042980Japanese Society of Hepato-Biliary-Pancreatic Surgery18
Completed
Not Applicable
Prognosis of patient with hepatocellular carcinoma in chronic hepaitits C.Hepatitis CJPRN-C000000227Ikeda Municipal Hospital100
Recruiting
Not Applicable
Development of hepatocellular carcinoma after hepatitis C virus eradication in interferon-free direct-acting antiviralsChronic hepatitis CJPRN-UMIN000027342Kyushu University2,000